Senestech (SNES) to Release Quarterly Earnings on Thursday

Senestech (NASDAQ:SNES) is expected to be releasing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Senestech to post earnings of ($0.37) per share and revenue of $0.6020 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 5:00 PM ET.

Senestech (NASDAQ:SNES) last posted its quarterly earnings data on Tuesday, May 12th. The company reported ($0.31) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.02. The business had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.63 million. Senestech had a negative return on equity of 67.60% and a negative net margin of 304.22%. On average, analysts expect Senestech to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Senestech Trading Down 5.2%

Senestech stock opened at $1.27 on Thursday. The stock has a 50-day moving average price of $1.55 and a 200 day moving average price of $1.75. Senestech has a 52 week low of $1.26 and a 52 week high of $6.24. The stock has a market cap of $6.73 million, a PE ratio of -0.67 and a beta of 0.28. The company has a current ratio of 8.91, a quick ratio of 7.79 and a debt-to-equity ratio of 0.02.

Insider Buying and Selling at Senestech

In other Senestech news, major shareholder Glenbrook Capital Management acquired 35,000 shares of the firm’s stock in a transaction dated Monday, July 20th. The shares were acquired at an average price of $1.47 per share, for a total transaction of $51,450.00. Following the completion of the acquisition, the insider directly owned 1,057,824 shares of the company’s stock, valued at $1,555,001.28. This trade represents a 3.42% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last 90 days, insiders acquired 143,773 shares of company stock worth $224,802. Corporate insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Senestech

Large investors have recently added to or reduced their stakes in the business. Millennium Management LLC acquired a new stake in Senestech in the 3rd quarter worth about $126,000. DRW Securities LLC increased its stake in shares of Senestech by 171.1% during the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock valued at $176,000 after acquiring an additional 51,818 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Senestech by 35.2% during the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock worth $306,000 after acquiring an additional 37,165 shares during the period. Jane Street Group LLC purchased a new position in shares of Senestech during the 2nd quarter worth about $161,000. Finally, Geode Capital Management LLC acquired a new stake in shares of Senestech in the second quarter worth approximately $59,000. 5.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of Senestech from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Senestech presently has an average rating of “Hold”.

Senestech Company Profile

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.